Abstract: The present invention relates to cancer therapy and to novel anticancer agents having a mechanism of action which is quite specific. It also relates to novel chemical compounds as well as their therapeutic application in humans.
Type:
Grant
Filed:
March 25, 2002
Date of Patent:
May 3, 2005
Assignee:
Aventis Pharma S.A.
Inventors:
Patrick Mailliet, Abdelazize Laoui, Jean-François Riou, Gilles Doerflinger, Jean-Louis Mergny, François Hamy, Thomas Caulfield